Virtual structure-based docking and molecular dynamics of FDA-approved drugs for the identification of potential IKKB inhibitors possessing dopaminergic activity in Alzheimer’s disease

被引：0
|
作者：
Prasada Chowdari Gurram
Sairaj Satarker
Ajmal Nassar
Jayesh Mudgal
Madhavan Nampoothiri
机构：
[1] Manipal Academy of Higher Education,Department of Pharmacology, Manipal College of Pharmaceutical Sciences
来源：
Chemical Papers | 2023年 / 77卷
关键词：
IKKB; Apomorphine; Rotigotine; Dopamine agonists; Neuroinflammation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1971 / 1988
页数：17
相关论文
共 50 条
  • [1] Virtual structure-based docking and molecular dynamics of FDA-approved drugs for the identification of potential IKKB inhibitors possessing dopaminergic activity in Alzheimer's disease
    Gurram, Prasada Chowdari
    Satarker, Sairaj
    Nassar, Ajmal
    Mudgal, Jayesh
    Nampoothiri, Madhavan
    CHEMICAL PAPERS, 2023, 77 (04) : 1971 - 1988
  • [2] Identification of Azelastine and Carvedilol as Cholinesterase Inhibitors via Structure-Based Virtual Screening of FDA-approved Drugs
    Sharma, Mohit
    Thakur, Shikha
    Jadhav, Hemant R. R.
    Bharate, Sandip B. B.
    CHEMISTRYSELECT, 2023, 8 (28):
  • [3] Structure-based virtual screening of FDA-approved drugs to discover potential inhibitors of phosphoinositide kinase, PIKfyve
    Wadje, Bhagyashri N.
    Somarowthu, Tejaswi
    Thakur, Shikha
    Jadhav, Hemant R.
    Bharate, Sandip B.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2024,
  • [4] Structure-Based Repurposing of FDA-Approved Drugs as TNF-α Inhibitors
    Leung, Chung-Hang
    Chan, Daniel Shiu-Hin
    Kwan, Maria Hiu-Tung
    Cheng, Zhen
    Wong, Chun-Yuen
    Zhu, Guo-Yuan
    Fong, Wang-Fun
    Ma, Dik-Lung
    CHEMMEDCHEM, 2011, 6 (05) : 765 - 768
  • [5] Structure-based virtual screening and molecular dynamics simulations of FDA-approved drugs targeting MALAT1
    Rocca, Roberta
    Alcaro, Stefano
    Artese, Anna
    MEDICINAL CHEMISTRY RESEARCH, 2024, 33 (11) : 2095 - 2100
  • [6] Identification of Potential Tryptase Inhibitors from FDA-Approved Drugs Using Machine Learning, Molecular Docking, and Experimental Validation
    Yasir, Muhammad
    Park, Jinyoung
    Han, Eun-Taek
    Park, Won Sun
    Han, Jin-Hee
    Chun, Wanjoo
    ACS OMEGA, 2024, 9 (37): : 38820 - 38831
  • [7] Structure-based screening of FDA-approved drugs and molecular dynamics simulation to identify potential leukocyte antigen related protein (PTP-LAR) inhibitors
    Du, Shan
    Zhang, Xin-Xin
    Gao, Xiang
    He, Yan-Bin
    COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2024, 113
  • [8] Structure-based virtual screening and molecular docking for the identification of potential biofilm inhibitors
    Praveen, Kumar
    Archana, Mohanan G.
    RESEARCH JOURNAL OF BIOTECHNOLOGY, 2020, 15 (04): : 107 - 115
  • [9] Structure-based screening of FDA-approved drugs identifies potential histone deacetylase 3 repurposed inhibitor: molecular docking and molecular dynamic simulation approaches
    Shamsi, Anas
    Khan, Mohd Shahnawaz
    Yadav, Dharmendra Kumar
    Shahwan, Moyad
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [10] Structure-based repurposing of FDA-approved drugs as inhibitors of NEDD8-activating enzyme
    Zhong, Hai-Jing
    Liu, Li-Juan
    Chan, Daniel Shiu-Hin
    Wang, Hui-Min
    Chan, Philip Wai Hong
    Ma, Dik-Lung
    Leung, Chung-Hang
    BIOCHIMIE, 2014, 102 : 211 - 215
12345